BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quaresma AB, Coy CSR, Damião AOMC, Kaplan GG, Kotze PG. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES. Arq Gastroenterol 2019;56:318-22. [DOI: 10.1590/s0004-2803.201900000-59] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Quaresma AB, Kotze PG. Reduction of surgical rates in inflammatory bowel diseases biologic era: Similarities between Spain and Latin America. J Gastroenterol Hepatol 2020;35:1453. [PMID: 32410307 DOI: 10.1111/jgh.15098] [Reference Citation Analysis]
2 Queiroz NSF, Martins CA, Quaresma AB, Hino AAF, Steinwurz F, Ungaro RC, Kotze PG. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry. J Gastroenterol Hepatol 2021. [PMID: 34151470 DOI: 10.1111/jgh.15588] [Reference Citation Analysis]
3 Senger PC, Zacharias P, Quaresma AB, Kotze PG. Inflammatory bowel disease epidemiology data from a prospective registry in Córdoba, Argentina: Raising the bar for future studies in Latin America. Dig Liver Dis 2021;53:1212-3. [PMID: 34001445 DOI: 10.1016/j.dld.2021.04.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Miranda EF, Nones RB, Kotze PG. Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn's disease: a narrative review. Intest Res 2021;19:255-64. [PMID: 33147899 DOI: 10.5217/ir.2020.00029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kotze PG, DamiÃo AOMC. Research in inflammatory bowel disease in Brazil: a step forward towards patient care. Arq Gastroenterol 2020;57:225-6. [PMID: 33206810 DOI: 10.1590/S0004-2803.202000000-43] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Tong X, Zheng Y, Li Y, Xiong Y, Chen D. Soluble ligands as drug targets for treatment of inflammatory bowel disease. Pharmacol Ther 2021;226:107859. [PMID: 33895184 DOI: 10.1016/j.pharmthera.2021.107859] [Reference Citation Analysis]
7 Kotze PG, Steinwurz F, Francisconi C, Zaltman C, Pinheiro M, Salese L, Ponce de Leon D. Review of the epidemiology and burden of ulcerative colitis in Latin America. Therap Adv Gastroenterol 2020;13:1756284820931739. [PMID: 32695230 DOI: 10.1177/1756284820931739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]